hydroxychloroquine has been researched along with Retinal Vein Occlusion in 3 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Retinal Vein Occlusion: Blockage of the RETINAL VEIN. Those at high risk for this condition include patients with HYPERTENSION; DIABETES MELLITUS; ATHEROSCLEROSIS; and other CARDIOVASCULAR DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Antiphospholipid syndrome is a rare cause of ocular vaso-occlusive disease, but is associated with significant systemic morbidity and mortality." | 2.48 | Antiphospholipid antibody syndrome. ( Foster, CS; Kruh, JN; Yang, P, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ebrahimiadib, N | 1 |
| Riazi-Esfahani, H | 1 |
| Heidari, M | 1 |
| Mahmoudi, A | 1 |
| Menet, J | 1 |
| Agrinier, N | 1 |
| Dufrost, V | 1 |
| Conart, JB | 1 |
| Wahl, D | 1 |
| Duprez, KA | 1 |
| Zuily, S | 1 |
| Yang, P | 1 |
| Kruh, JN | 1 |
| Foster, CS | 1 |
1 review available for hydroxychloroquine and Retinal Vein Occlusion
| Article | Year |
|---|---|
Antiphospholipid antibody syndrome.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotein I; Humans; Hyd | 2012 |
2 other studies available for hydroxychloroquine and Retinal Vein Occlusion
| Article | Year |
|---|---|
Ocular flare-up in patients with systemic lupus erythematosus following discontinuation of hydroxychloroquine.
Topics: Aged; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Middle Aged; Retinal | 2020 |
Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Eye Disease | 2021 |